Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 115

AbSci absorbs $125m

New and existing investors provided crossover financing for the synthetic biology technology developer, which already counts Merck & Co, AGC Asahi Glass and JSR Life Sciences as investors.

Mar 25, 2021

Recursion takes steps toward $100m IPO

Bayer could exit the drug discovery technology developer should it complete an initial public offering on the Nasdaq Global Select Market.

Mar 25, 2021

Renovacor reaches reverse merger deal

The Novartis-backed gene therapy developer will merge with Chardan Healthcare Acquisition 2 Corp and take a New York Stock Exchange listing.

Mar 25, 2021

Helsinn hails 3B Future Health Fund II

Helsinn is co-anchoring the second 3B Future Health Fund, which will target oncology and rare disease therapeutics startups as it seeks a $118m close.

Mar 25, 2021

1910 Genetics makes $22m date with Microsoft

M12 co-led a $22m series A round for the drug discovery technology developer with Playground Global, and both investors have taken board seats.

Mar 24, 2021

AppliedVR accelerates with $29m

Cedars-Sinai contributed to a round boosting the virtual reality therapeutics developer's overall funding to $35m.

Mar 24, 2021

JSR Life Sciences forms corporate venturing fund

JSR Life Sciences Corporate Venture Fund will invest in developers of innovative drug research, development or manufacturing technology.

Mar 24, 2021

Jianhai Technology jumps to $23m series B

The iFlytek-backed post-discharge care management platform received $23m in a round led by Sequoia Capital China.

Mar 24, 2021

Appriss approves $500m PatientPing acquisition

Appriss Health is paying a reported $500m to buy healthcare collaboration platform developer PatientPing, allowing Alphabet's GV to exit.

Mar 24, 2021

Medipal meditates on $92m corporate venturing fund

SBI Investment will help manage the drug distributor’s Medipal Innovation Fund, which will invest in entrepreneurs in areas such as drug discovery and healthcare.

Mar 24, 2021
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here